Stay updated on Pembrolizumab and Chemoradiation in Head and Neck Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab and Chemoradiation in Head and Neck Clinical Trial page.

Latest updates to the Pembrolizumab and Chemoradiation in Head and Neck Clinical Trial page
- Check4 days agoChange DetectedLocation listings were updated to add numerous sites across the United States, Australia, and various other countries. Several existing sites were removed.SummaryDifference2%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedRevision: v3.3.2 has been added. Revision: v3.3.1 has been removed.SummaryDifference0.0%

- Check33 days agoChange DetectedA note was added clarifying that publications are automatically filled from PubMed, and the page revision is updated to v3.3.1.SummaryDifference0.0%

- Check40 days agoChange DetectedAdded Tainan, Taiwan, 70403 as a study location and replaced the entry 'Tainan City, Taiwan, 70403' with 'Tainan, Taiwan, 70403' in the location list.SummaryDifference0.2%

- Check54 days agoChange DetectedThe new screenshot shows only minor UI changes and updated timestamps; core study content such as Study Details, Eligibility Criteria, Interventions, and Outcomes remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check61 days agoChange DetectedLocation entries for Cali, Valle del Cauca Department, Colombia (postal codes 760032 and 760042) were updated, replacing 'Santiago de Cali' with the standardized city name. This update standardizes naming without altering available sites or study procedures.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab and Chemoradiation in Head and Neck Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Chemoradiation in Head and Neck Clinical Trial page.